Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer

Radiotherapy and Oncology

Volumn 83, Issue 2, 2007, Pages 148-155

  Pötter, Richard ^a   Dimopoulos, Johannes ^a   Georg, Petra ^a   Lang, Stefan ^a   Waldhäusl, Claudia ^a   Wachter Gerstner, Natascha ^a   Weitmann, Hajo ^a   Reinthaller, Alexander ^b   Knocke, Tomas Hendrik ^a   Wachter, Stefan ^a   Kirisits, Christian ^a  

^a Department of Radiotherapy and Radiobiology ^*

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

3D MRI based brachytherapy; Cervix cancer

Indexed keywords

CISPLATIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLADDER DISEASE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER LOCALIZATION; CANCER PREVENTION; CANCER REGRESSION; CANCER RISK; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CLINICAL STUDY; COLON DISEASE; CONTROLLED STUDY; EXTERNAL BEAM RADIOTHERAPY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HISTOGRAM; HUMAN; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIATION DOSE; RECTUM DISEASE; SMALL INTESTINE DISEASE; TREATMENT OUTCOME; UTERINE CERVIX CANCER; VAGINA DISEASE;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BRACHYTHERAPY; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; RADIOTHERAPY DOSAGE; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 34249091765     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2007.04.012     Document Type: Article

References (28)

1. van de Bunt L., van der Heide U.A., Ketelaars M., de Kort G.A., and Jurgenliemk-Schulz I.M. Conventional, conformal, and intensity-modulated radiation therapy treatment planning of external beam radiotherapy for cervical cancer: The impact of tumor regression. Int J Radiat Oncol Biol Phys 64 (2006) 189-196
2. Gerbaulet A., Pötter R., and Haie-Meder C. Cervix cancer. In: Gerbaulet A., Pötter R., Mazeron J.J., Meertens H., and Van Limbergen E. (Eds). The GEC ESTRO handbook of brachytherapy (2002), ESTRO, Brussels 301-363
3. Wachter-Gerstner N., Wachter S., Reinstadler E., et al. The impact of sectional imaging on dose escalation in endocavitary HDR-brachytherapy of cervical cancer: results of a prospective comparative trial. Radiother Oncol 68 (2003) 51-59
4. Haie-Meder C., Pötter R., Van Limbergen E., et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 74 (2005) 235-245
5. Pötter R., Haie-Meder C., Van Limbergen E., et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 78 (2006) 67-77
6. Fransson A., Andreo P., and Pötter R. Aspects of MR image distortion in radiotherapy treatment planning. Strahlenther Onkol 177 (2001) 59-73
7. Dimopoulos J.C.A., Schard G., Berger D., et al. Systematic evaluation of MRI findings in different stages of treatment of cervical cancer: Potential of MRI on delineation of target, pathoanatomic structures, and organs at risk. Int J Radiat Oncol Biol Phys 64 (2006) 1380-1388
8. Fellner C., Pötter R., Knocke T.H., and Wambersie A. Comparison of radiography- and computed tomography-based treatment planning in cervix cancer in brachytherapy with specific attention to some quality assurance aspects. Radiother Oncol 58 (2001) 53-62
9. Kirisits C., Pötter R., Lang S., Dimopoulos J., Wachter-Gerstner N., and Georg D. Dose and volume parameters for MRI based treatment planning in intracavitary brachytherapy of cervix cancer. Int J Radiat Oncol Biol Phys 62 (2005) 901-911
10. Gerstner N., Wachter S., Knocke T.H., Fellner C., Wambersie A., and Pötter R. The benefit of Beam's eye view based 3D treatment planning for cervical cancer. Radiother Oncol 51 (1999) 71-78
11. Pötter R., Knocke T.H., Fellner C., Baldass M., Reinthaller A., and Kucera H. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations. Cancer Radiother 4 (2000) 159-172
12. Dimopoulos J.C., Kirisits C., Petric P., et al. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: clinical feasibility and preliminary results. Int J Radiat Oncol Biol Phys. 66 (2006) 83-90
13. Kirisits C., Lang S., Dimopoulos J., Berger D., Georg D., and Pötter R. The Vienna applicator for combined intracavitary and interstitial brachytherapy of Cervical Cancer: Desgin, application, treatment planning and dosimetric results. Int J Radiat Oncol Biol Phys 65 (2006) 624-630
14. Joiner M.C., and Bentzen S.M. Time-dose relationships. The linear-quadratic approach. In: Steel G.G. (Ed). Basic clinical radiobiology. 3rd ed. (2002), Arnold, London 120-133
15. Pötter R., Dimopoulos J., Bachtiary B., et al. 3D conformal HDR-brachy- and external beam therapy plus simultan eous Cisplatin for high-risk cervical cancer: Clinical experience with 3 year follow-up. Radiother Oncol 79 (2006) 80-86
16. LENT SOMA tables. Radiother Oncol 1995;35:17-60.
17. Pötter R., Kirisits C., and Lievens Y. What kind of equipment do we need in gynaecological brachytherapy? Clinical, technical and economical aspects for standard and new techniques. Radiother Oncol 75 (2005) S1
18. Joslin C.A., Smith C.W., and Mallik A. The treatment of cervix cancer using high activity 60 Co sources. Br J Radiol 45 (1972) 257-270
19. Joslin C.A.F. High dose-rate brachytherapy for treating cervix cancer. In: Joslin C.A.F., Flynn A., and Hall E. (Eds). Principles and practice of brachytherapy using afterloading systems (2001), Arnold, London 354-372
20. Petereit D.G., Sarkaria J.N., Potter D.M., and Schink J.C. High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence - the University of Wisconsin experience. Int J Radiat Oncol Biol Phys 45 (1999) 1267-1274
21. Fletcher G.H., and Hamburger A.D. Female pelvis. squamous cell carcinoma of the uterine cervix. In: Fletcher G.H. (Ed). Textbook of radiotherapy. 3rd ed. (1980), Lea and Febiger, Philadelphia 720-789
22. Horiot J.C., Pigneux J., Pourquier H., et al. Radiotherapy alone in carcinoma of intact uterine cervix according to Fletcher guidelines: a French cooperative study of 1383 cases. Int J Radiat Oncol Biol Phys 14 (1988) 605-611
23. Perez C.A., Fox S., Lockett M.A., et al. Impact of dose in outcome of irradiation alone in carcinoma of the uterine cervix: analysis of two different methods. Int J Radiat Oncol Biol Phys 21 (1991) 885-898
24. Eifel P.J., Thoms Jr. W.W., Smith T.L., Morris M., and Oswald M.J. The relationship between brachytherapy dose and outcome in patients with bulky endocervical tumors treated with radiation alone. Int J Radiat Oncol Biol Phys 28 (1994) 113-119
25. Eifel P.J., Morris M., Wharton J.T., and Oswald M.J. The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 29 (1994) 9-16
26. Eifel P.J., Winter K., Morris M., et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol 22 (2004) 872-880
27. Logsdon M.D., and Eifel P.J. FIGO IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy. Int J Radiat Oncol Biol Phys 43 (1999) 763-775
28. Gerbaulet A., Michel G., Haie-Meder C., et al. The role of low dose rate brachytherapy in the treatment of cervix carcinoma. Experience of the Gustave-Roussy Institute on 1245 patients. Eur J Gynaecol Oncol 16 (1995) 461-475